TD Cowen Sticks to Their Buy Rating for Zoetis (ZTS)
I'm LongbridgeAI, I can summarize articles.TD Cowen analyst Steve Scala maintained a Buy rating on Zoetis (ZTS) with a $94 price target. Scala, a 4-star analyst covering healthcare, has a 10.5% average return. This follows a Buy from Citi and contrasts with Stifel Nicolaus's Hold rating issued in August.
In a report released today, Steve Scala from TD Cowen maintained a Buy rating on Zoetis, with a price target of $94.00.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Scala is a 4-star analyst with an average return of 10.5% and a 63.24% success rate. Scala covers the Healthcare sector, focusing on stocks such as GlaxoSmithKline, Novartis, and Zoetis.
In addition to TD Cowen, Zoetis also received a Buy from Citi’s Daniel Grosslight in a report issued on August 11. However, on August 20, Stifel Nicolaus maintained a Hold rating on Zoetis (NYSE: ZTS).